Related references
Note: Only part of the references are listed.Drug Development: Portals of Discovery
Susan E. Bates et al.
CLINICAL CANCER RESEARCH (2012)
The aromatic ketone 4′-hydroxychalcone inhibits TNFα-induced NF-κB activation via proteasome inhibition
Barbora Orlikova et al.
BIOCHEMICAL PHARMACOLOGY (2011)
NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
Han-Ming Shen et al.
APOPTOSIS (2009)
Identification of methysticin as a potent and non-toxic NF-κB inhibitor from kava, potentially responsible for kava's chemopreventive activity
Ahmad Ali Shaik et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Structure-Activity Relationship Studies of Chalcone Leading to 3-Hydroxy-4,3′,4′,5′-tetramethoxychalcone and Its Analogues as Potent Nuclear Factor κB Inhibitors and Their Anticancer Activities
Balasubramanian Srinivasan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Population-Based Trends in Lung Cancer Incidence in Women
Brian L. Egleston et al.
SEMINARS IN ONCOLOGY (2009)
Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Yong Lin et al.
CURRENT CANCER DRUG TARGETS (2008)
Coix seed extract, a commonly used treatment for cancer in china, inhibits NFκB and protein kinase C signaling
Ju- Hyung Woo et al.
CANCER BIOLOGY & THERAPY (2007)
Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-κB (NF-κB) signaling pathway leading to suppression of NF-κB-regulated antiapoptotic and metastatic gene products
Kwang Seok Ahn et al.
MOLECULAR PHARMACOLOGY (2007)
Zyflamend, a polyherbal preparation, inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of NF-kappa B activation and NF-kappa B-regulated gene products
Santosh K. Sandur et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2007)
Inflammation and cancer: How hot is the link?
Bharat B. Aggarwal et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Transcriptional activation of survivin through the NF-κB pathway by human T-cell leukemia virus type I Tax
H Kawakami et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells
YL Hsu et al.
LIFE SCIENCES (2004)
Cytotoxic 2′,5′-dihydroxychalcones with unexpected antiangiogenic activity
NH Nam et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Cytotoxic and inhibitory effects of 4,4-dihydroxy chalcone (RVC-588) on proliferation of human leukemic HL-60 cells
G Saydam et al.
LEUKEMIA RESEARCH (2003)
Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-κB activation
KY Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2002)
Dietary agents in cancer prevention: flavonoids and isoflavonoids
DF Birt et al.
PHARMACOLOGY & THERAPEUTICS (2001)
Share Paper
